V
Valeriya Malysheva
Researcher at Imperial College London
Publications - 15
Citations - 279
Valeriya Malysheva is an academic researcher from Imperial College London. The author has contributed to research in topics: Gene regulatory network & Enhancer. The author has an hindex of 7, co-authored 13 publications receiving 139 citations. Previous affiliations of Valeriya Malysheva include Control Group & Babraham Institute.
Papers
More filters
Journal ArticleDOI
Cohesin-Dependent and -Independent Mechanisms Mediate Chromosomal Contacts between Promoters and Enhancers
Michiel J. Thiecke,Gordana Wutz,Matthias Muhar,Wen Tang,Stephen Bevan,Valeriya Malysheva,Valeriya Malysheva,Roman R. Stocsits,Tobias Neumann,Johannes Zuber,Peter Fraser,Peter Fraser,Stefan Schoenfelder,Jan-Michael Peters,Mikhail Spivakov,Mikhail Spivakov +15 more
TL;DR: This work uses high-resolution Capture Hi-C to interrogate the dynamics of chromosomal contacts of all annotated human gene promoters upon degradation of cohesin and CTCF, and shows that a majority of promoter-anchored contacts are lost in these conditions, but many contacts with distinct properties are maintained, and some new ones are gained.
Journal ArticleDOI
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Jessica Sook Yuin Ho,Bobo Wing-Yee Mok,Laura Campisi,Tristan X. Jordan,Soner Yildiz,Sreeja Parameswaran,Joseph A. Wayman,Joseph A. Wayman,Natasha N. Gaudreault,David A. Meekins,Sabarish V. Indran,Igor Morozov,Jessie D. Trujillo,Yesai Fstkchyan,Raveen Rathnasinghe,Zeyu Zhu,Simin Zheng,Nan Zhao,Kris M. White,Helen Ray-Jones,Valeriya Malysheva,Michiel J. Thiecke,Siu Ying Lau,Honglian Liu,Anna Junxia Zhang,Andrew Chak-Yiu Lee,Wen-Chun Liu,Sonia Jangra,Alba Escalera,Teresa Aydillo,Betsaida Salom Melo,Ernesto Guccione,Robert Sebra,Elaine Shum,Jan Bakker,Jan Bakker,Jan Bakker,David A. Kaufman,Andre L. Moreira,Mariano Carossino,Udeni B. R. Balasuriya,Minji Byun,Randy A. Albrecht,Michael Schotsaert,Adolfo García-Sastre,Sumit K. Chanda,Emily R. Miraldi,Emily R. Miraldi,Anand D. Jeyasekharan,Benjamin R. tenOever,Mikhail Spivakov,Matthew T. Weirauch,Matthew T. Weirauch,Sven Heinz,Honglin Chen,Christopher Benner,Juergen A. Richt,Ivan Marazzi +57 more
TL;DR: In this paper, using multidimensional epigenetic, transcriptional, in-vitro, and invivo analyses, the authors reported that topoisomerase 1 (TOP1) inhibition suppresses lethal inflammation induced by SARS-CoV-2.
Journal ArticleDOI
Reconstructed cell fate-regulatory programs in stem cells reveal hierarchies and key factors of neurogenesis
Marco Antonio Mendoza-Parra,Valeriya Malysheva,Mohamed Ashick Mohamed Saleem,Michele Lieb,Aurelie Godel,Hinrich Gronemeyer +5 more
TL;DR: This study demonstrates that a systems view of cell fate specification combined with computational signal transduction models provides the necessary insight in cellular plasticity for cell fate engineering and can be used to monitor the in vitro capacity of cells/tissues to establish cell lineages for regenerative medicine.
Journal ArticleDOI
Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis
TL;DR: This is the first comprehensive view of the gene regulatory network that is altered during the process of stepwise human cellular tumorigenesis in a virtually isogenic system and suggests a direct implication of CRMs in oncogene-induced tumorsigenesis and identifies new CRMs involved in this process.
Journal ArticleDOI
Detecting chromosomal interactions in Capture Hi-C data with CHiCAGO and companion tools.
Paula Freire-Pritchett,Helen Ray-Jones,Helen Ray-Jones,Monica Della Rosa,Monica Della Rosa,Chris Eijsbouts,William R. Orchard,Steven Wingett,Steven Wingett,Chris Wallace,Jonathan Cairns,Mikhail Spivakov,Mikhail Spivakov,Valeriya Malysheva,Valeriya Malysheva +14 more
TL;DR: The Capture Hi-C Analysis of Genomic Organization (CHiCAGO) as mentioned in this paper is a computational pipeline developed specifically for Capture HiC analysis, which implements a statistical model accounting for biological and technical background components, as well as bespoke normalization and multiple testing procedures.